[Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification]. 1988

T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
Department of Urology, Kitasato University School of Medicine.

One hundred and sixty-seven patients with newly diagnosed, previously untreated prostatic adenocarcinoma, during the period between July, 1971 and March, 1934, were studied. The histopathologic specimens of the prostate were classified by the Japanese General Rules of Prostatic Cancer (JGRPC) and by Gleason's classification. The number of patients with well, moderately and poorly differentiated prostatic carcinomas according to the JGRPC classification was 42, 74 and 51 respectively, and the number of the patients with Gleason's pattern 1, 2, 3, 4, and 5 was 24, 20, 32, 43 and 48, respectively. The number of patients with Gleason's score (primary plus secondary pattern) 2 to 4, 5 to 7 and 8 to 10 groups was 40, 76 and 51 respectively. There was no significant difference in survival rate between well and moderately differentiated groups, but the survival rate of the group with poorly differentiated tumor was significantly lower than that of the moderately differentiated (p less than 0.01) and well differentiated (p less than 0.001) groups. There was no significant difference in 10-year survival rate between the score 2-4 and score 5-8 groups, but the score 9-10 group had a significantly lower survival rate than the score 5-8 group (p less than 0.01) and score 2-4 (p less than 0.005) group. JGRPC and Gleason's classification are thought to be equally useful in estimating prognosis of prostatic cancer, but the former is more concise and easily applicable than the latter.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
August 1990, Hinyokika kiyo. Acta urologica Japonica,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
July 2000, Nihon rinsho. Japanese journal of clinical medicine,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
October 2001, International journal of urology : official journal of the Japanese Urological Association,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
September 2011, Zhonghua bing li xue za zhi = Chinese journal of pathology,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
March 1990, Zhonghua bing li xue za zhi = Chinese journal of pathology,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
August 1980, The Journal of urology,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
January 1991, Annales de pathologie,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
February 2002, JPMA. The Journal of the Pakistan Medical Association,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
January 2001, Anticancer research,
T Uchida, and M Go, and H Nakajo, and Y Takagi, and M Murayama, and N Honda, and M Igarashi, and A Ishibashi, and K Koshiba
January 1999, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie,
Copied contents to your clipboard!